Medical Patent Seekers Breathe Sigh of Relief
(HealthTech Wire, February 11, 2008) Medical patent seekers--and patent seekers in other communities for that matter--are relieved by the rejection of section 4 of the Patent Reform Act of 2007, which would have limited penalties for patent infringement.
Medical Patent Opportunities in Bloodless Solutions
Medical patent opportunities for "bloodless solutions" have been actualized in a wide range of medical devices in technology. With patients increasingly concerned with the risks associated with transfusions, the trend appears to be growing.
Patent Pending Drug for Artherosclerosis
Merck & Co, Inc., in collaboration with Arena Pharmaceuticals, is taking a patent pending drug into Phase One of a clinical trial (PharmaLive, January 25, 2008). Merck’s second generation niacin receptor agonist is a combatant to artherosclerosis. Will the patented drug enter the market? ... Read More
Patent Revocation: A Significant Risk?
I posted the information below in a separate blog I run for people interested in non-medical patents. However, I thought it would be of use to this community as well. The question being discussed is how ‘at-risk’ patent holders are for having their patents revoked. And the short answer is…very little. . T... Read More
A Patent-Pending Patent Protector?
How are you imbuing authenticity within your product's concept? When an idea is innovative enough, being first is itself the strongest voice of authenticity.
